Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Anaglin Injection 50% is a high-concentration pharmaceutical solution of Anagrelide, primarily synthesized via chemical condensation. This active ingredient functions as a potent PDE3 inhibitor used to manage thrombocythemia. Its molecular structure is defined by the formula C12H14N4O2 and carries the CAS registry number 86937-57-3.
Strictly contraindicated for patients with severe heart failure or uncontrolled arrhythmias. Storage requires temperatures below 25°C in a dry environment away from direct sunlight. Medical personnel must adhere to PPE protocols during handling to prevent dermal absorption.